Source: Eur Respir Rev 2006; 15: 105-106



Rating:

Share or cite this content

Citations should be made in the following way:
Fehrenbach H.. There is no rationale to still rely on outdated, biased tools for quantitative morphology in pulmonary research. Eur Respir Rev 2006; 15: 105-106

Member's Comments

No comment yet.

Related content which might interest you: HOPE-BAL: A novel tool to expand the methodological capabilities in pulmonary research Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease Year: 2012 The limitations of quantitative measures: assessing approaches to research into NIV use in MND Source: Annual Congress 2009 - New trends in noninvasive ventilation for chronic respiratory failure Year: 2009 Where do we stand with asthma phenotypes derived from data-driven methods? A systematic review Source: International Congress 2019 – Respiratory function assessment in disease Year: 2019 Some principles and practices of genetic biobanking studies Source: Eur Respir J 2009; 33: 419-425 Year: 2009 COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020 Year: 2020 How to apply evidence based practice critique method to review of guidelines Source: Annual Congress 2005 - Workshop: evidence-based practice: an approach to care Year: 2005 What kind of emphasis do we need in clinical research to enable personalised respiratory medicine? Source: Eur Respir J, 55 (1) 1901866; 10.1183/13993003.01866-2019 Year: 2020 Developing a novel in vitro 3D airway model to provide a viable alternative to animal use in asthma research Source: Annual Congress 2012 - Cell culture and animal models of lung disease Year: 2012 Applying sputum as a diagnostic tool in pneumonia - limited yield, minimal impact on treatment decisions Source: Eur Respir J 2001; 18: Suppl. 33, 502s Year: 2001 The impact of a new recruitment strategy to improve recruitment of participants to research studies Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness Year: 2019 Utilising data from single cell approaches to study existing and recently emerging lung diseases? Source: Virtual Congress 2021 – Utilising data from single cell approaches to study existing and recently emerging lung diseases? Year: 2021 Some current challenges in statistical methods to illuminate disease genetics Source: Research Seminar 2009 - Post Genome Respiratory Epidemiology II - An interdisciplinary challenge Year: 2008 Qualitative research evaluating patient preferences for a new COPD treatment Source: International Congress 2018 – Patient-reported outcomes and scores in COPD Year: 2018 Revising our approach to conducting therapeutic clinical research in COPD Source: Eur Respir J, 51 (2) 1702712; 10.1183/13993003.02712-2017 Year: 2018 Using qualitative methods to explore the implementation of diagnostics in primary care Source: Value-Dx event 2019: VALUE-Dx kick off meeting and course Year: 2019 Identification of lung transplant candidates, stratification of risk, lung allocation and quality control in Europe using real-time decision-making and big data: lessons learned and future perspectives Source: Virtual Congress 2021 – Lung graft allocation and monitoring in the 21st century Year: 2021 The forced oscillation technique in clinical practice: methodology, recommendations and future developments Source: Guideline 2003 Year: 2003 Establishment of an integrated clinical network and comprehensive data warehouse for the conduct of comparative effectiveness research in COPD Source: Annual Congress 2011 - COPD: integrated care and rehabilitation Year: 2011 A novel image based method for the evaluation of regional changes in lung mechanics Source: Annual Congress 2008 - New imaging techniques in chest imaging Year: 2008